Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Oct. 09, 2022
Apr. 30, 2022
Apr. 19, 2022
Apr. 19, 2022
Apr. 14, 2022
Apr. 13, 2022
Mar. 22, 2022
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Mar. 21, 2022
Dec. 31, 2021
Apr. 18, 2019
Dec. 11, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Common stock, share authorized             100,000,000 100,000,000 100,000,000   50,000,000 100,000,000 50,000,000 20,000,000
Common stock, par value               $ 0.0001 $ 0.0001     $ 0.0001   $ 0.0001
Preferred stock, shares authorized             1,000,000 1,000,000 1,000,000   10,000 1,000,000 10,000  
Preferred stock, par value             $ 0.0001 $ 0.0001 $ 0.0001   $ 0.001 $ 0.0001 $ 0.001  
Conversion of Stock, Description             Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation              
Warrants exercise price $ 5.32                          
Net proceeds from ipo                 $ 14,202,975        
Common stock issued for services, shares                 35,000          
Common stock issued for services, value               $ 60,551 $ 60,551          
Warrant remeasurement liability                 2,401,338          
Fair value of warrants                 $ 228,655          
Volatility                 93.47%          
Risk free interest rate                 2.77%          
Dividend rate                 0.00%          
Note Purchase Agreement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Common stock issued for services, shares                 235,295          
IPO [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants received               187,500 187,500          
Net proceeds from ipo       $ 14,200,000 $ 14,200,000                  
Warrant remeasurement liability                 $ 5,778,750          
Warrants cost               $ 11,250 $ 11,250          
Trading Warrants [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Issuance of warrants   7,500,000                        
OverAllotment Warrants [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Issuance of warrants   1,125,000                        
Note Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants exercise price                 $ 4.25          
Issuance of warrants     235,295                      
Note Warrant [Member] | Note Purchase Agreement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants exercise price                 $ 4.25          
Fair value of warrants                 $ 520,000          
Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Initial public offering           3,750,000                
Warrants exercise price           $ 4.25                
Warrants exercise price term           5 years                
Warrants received           1,125,000                
Fair value of warrants               $ 3,378,412 $ 3,378,412